Acetylcholinesterase Inhibitors: Treatment of Dementia-Related Behavioral Disturbances
نویسندگان
چکیده
منابع مشابه
Behavioral disturbances in dementia
Psychological symptoms and behavioral abnormalities are common and prominent characteristics of dementia. They include symptoms such as depression, anxiety psychosis, agitation, aggression, disinhibition, and sleep disturbances. Approximately 30% to 90% of patients with dementia suffer from such behavioral disorders. There are complex interactions between cognitive deficits, psychological sympt...
متن کاملThe treatment of behavioral disturbances and psychosis associated with dementia.
Behavioral disturbances and psychosis associated with dementia are becoming an increasingly common cause of morbidity in patients with dementia. Approximately 70% of individuals with dementia will experience agitation, and 75% will experience symptoms of psychosis such as delusions or hallucinations. The goal of this article is to review the pharmacologic treatment options for behavioral distur...
متن کامل[Use of acetylcholinesterase inhibitors and memantine in Alzheimer-type dementia].
BACKGROUND The therapeutic options to treat Alzheimer-type dementia (ATD) in recent years, have made it increasingly necessary to become familiar with the employment pattern of these new medicinal products. METHODS A cross-sectional observational study of the population with ATD treated with acetylcholinesterase inhibitors and/or memantine in the Gallician Health Service. Databases were compi...
متن کاملToward the Automatic Assessment of Behavioral Disturbances of Dementia
Advances in healthcare have dramatically increased life expectancy in the United States over the course of the last century. The challenges of caring for a graying population are exemplified by Alzheimer‘s disease (AD), the most common cause of dementia among persons age 65 and older. The current annual direct and indirect cost of 100 billion dollars devoted to dementia care will increase as th...
متن کامل[Acetylcholinesterase inhibitors for treatment of Alzheimer's disease].
Alzheimer's disease (AD) is a neurodegenerative disorder, and is the commonest cause of dementia. Acetylcholinesterase inhibitors (AChEIs) were developed under the cholinergic hypothesis of AD. Therapeutic strategies with these drugs aimed to enhance cholinergic neurotransmission in specific parts of the brain, and to improve the clinical symptoms of AD. Donepezil, galantamine and rivastigmine ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Primary Care Companion to The Journal of Clinical Psychiatry
سال: 2000
ISSN: 1523-5998
DOI: 10.4088/pcc.v02n0607